Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: An in vivo 1H MRS study

Journal of Magnetic Resonance Imaging

Volumn 33, Issue 4, 2011, Pages 855-863

  Thakur, Sunitha B ^a   Brennan, Sandra B ^a   Ishill, Nicole M ^a   Morris, Elizabeth A ^a   Liberman, Laura ^a   Dershaw, D David ^a   Bartella, Lia ^a   Koutcher, Jason A ^a   Huang, Wei ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Breast lesions; Choline concentration; Proton MR spectroscopy; Water to fat ratio

Indexed keywords

CHOLINE;

ADULT; AGED; ARTICLE; BIOCHEMICAL COMPOSITION; BREAST; BREAST CANCER; BREAST CARCINOMA; BREAST EXAMINATION; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; IMAGE PROCESSING; IN VIVO STUDY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; WATER TO FAT RATIO;

ADIPOSE TISSUE; ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BODY WATER; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CHOLINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MODELS, STATISTICAL; ROC CURVE;

EID: 79953234507     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22493     Document Type: Article

References (42)

1. Liberman L. Breast cancer screening with MRI-what are the data for patients at high risk? N Engl J Med 2004;351:497-500.
2. Ghai S, Muradali D, Bukhanov K, Kulkarni S. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. AJR Am J Roentgenol 2005;185:481-487.
3. Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild HH, Gieseke J. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 2006;239:666-676. (Pubitemid 43830601)
4. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006;238:42-53. (Pubitemid 43010579)
5. Nunes LW, Schnall MD, Orel SG, et al. Correlation of lesion appearance and histologic findings for the nodes of a breast MR imaging interpretation model. Radiographics 1999;19:79-92.
6. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004;232:585-591. (Pubitemid 38971303)
7. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.
8. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy- initial results. Radiology 2001;220:40-46. (Pubitemid 32577957)
9. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006;239:686-692. (Pubitemid 43830603)
10. Bartella L, Thakur SB, Morris EA, et al. Enhancing nonmass lesions in the breast: evaluation with proton 1H MR spectroscopy. Radiology 2007;245:80-87. (Pubitemid 47417790)
11. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy. J Magn Reson Imaging 1999;10:159-164. (Pubitemid 29362430)
12. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45-54. (Pubitemid 32928270)
13. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84:1016-1022. (Pubitemid 32448495)
14. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002;94:1197-1203. (Pubitemid 34993869)
15. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269-275. (Pubitemid 28464677)
16. Bakken IJ, Gribbestad IS, Singstad TE, Kvistad KA. External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 2001;46:189-192. (Pubitemid 32592153)
17. Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003;50:1134-1143.
18. Thakur SB, Bartella L, Ishill NM, et al. Comparisons of water-tofat ratios in malignant, benign breast lesions, and normal breast parenchyma: an in vivo proton MRS study. In Proceedings of the 14th Annual Meeting of ISMRM, Seattle, Washington, 2006. (abstract 2874).
19. Thakur SB, Bartella L, Ishill NM, et al. Discrimination of choline-positive invasive breast carcinomas using water-to-fat ratio: a proton MRS study. In Proceedings of the 14th Annual Meeting of ISMRM. Seattle, Washington, 2006. (abstract 578).
20. Meisamy S, Bolan PJ, Baker EH, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy-a pilot study at 4 T. Radiology 2004;233:424-431.
21. Manton D, Chaturvedi A, Hubbard A, et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006;94:427-435. (Pubitemid 43237566)
22. Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661-666. (Pubitemid 27369023)
23. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80-84. (Pubitemid 29062961)
24. Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002;225:190-197.
25. Kiricuta I-C Jr, Simplaceanu V. Tissue water content and nuclear magnetic resonance in normal and tumor tissues. Cancer Res 1975;35:1164-1167.
26. Jagannathan NR, Singh M, Govindaraju V, et al. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed 1998;11:414-422. (Pubitemid 29031851)
27. Sharma U, Kumar M, Sah RG, Jagannathan NR. Study of normal breast tissue by in vivo volume localized proton MR spectroscopy: variation of water-fat ratio in relation to the heterogeneity of the breast and the menstrual cycle. Magn Reson Imaging 2009;27:785-791.
28. Kumar M, Jagannathan NR, Seenu V, Dwivedi SN, Julka PK, Rath GK. Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study. J Magn Reson Imaging 2006;24:325-332. (Pubitemid 44188558)
29. Rutgers DR, van der Grond J. Relaxation times of choline, creatine and N-acetyl aspartate in human cerebral white matter at 1.5 T. NMR Biomed 2002;15:215-221. (Pubitemid 34520661)
30. Rakow-Penner R, Daniel B, Yu H, Sawyer-Glover A, Glover GH. Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL. J Magn Reson Imaging 2006;23:87-91. (Pubitemid 43100723)
31. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
32. Bolan PJ, Nelson MT, Yee D, Garwood M. Imaging in breast cancer: magnetic resonance spectroscopy. Breast Cancer Res 2005;7:149-152. (Pubitemid 40872777)
33. Meisamy S, Bolan PJ, Baker EH, et al. Adding in vivo quantitative1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 2005;236:465-475.
34. Jagannathan NR, Kumar M, Raghunathan P, Coshic O, Julka PK, Rath GK. Assessment of therapeutic response of human breast carcinoma using in-vivo volume localized proton magnetic resonance spectroscopy. Curr Sci 1999;76:777-782. (Pubitemid 129558264)
35. Thomas MA, Binesh N, Yue K, DeBruhl N. Volume-localized twodimensional correlated magnetic resonance spectroscopy of human breast cancer. J Magn Reson Imaging 2001;14:181-186. (Pubitemid 32709479)
36. Bakker CJ, Vriend J. 1H spin-lattice relaxation studies of tissue response to radiotherapy in mice. Phys Med Biol 1983;28:331-340. (Pubitemid 13118803)
37. Sinha S, Lucas-Quesada FA, Sinha U, DeBruhl N, Bassett LW. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 2002;15:693-704.
38. Sinha S, Sinha U. Functional magnetic resonance of human breast tumors: diffusion and perfusion imaging. Ann N Y Acad Sci 2002;980:95-115. (Pubitemid 36135491)
39. Hatakenaka M, Soeda H, Yabuuchi H, et al. Apparent diffusion coefficients of breast tumors: clinical application. Magn Reson Med Sci 2008;7:23-29.
40. Woodhams R, Matsunaga K, Iwabuchi K, et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005;29:644-649. (Pubitemid 41395779)
41. Qayyum A, Birdwell RL, Daniel BL, et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 2002;178:1227-1232. (Pubitemid 34411425)
42. Morris EA, Liberman L. Breast MRI: diagnosis and intervention. New York, NY: Springer; 2005. 513 p.